Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04095689 |
| Title | TAC Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy and L-NMMA in Triple Negative Breast Cancer |
| Acronym | INTEGRAL |
| Recruitment | Suspended |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | The Methodist Hospital System |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |